Detalhe da pesquisa
1.
Clinical course and outcome of SARS-CoV-2 infection in multiple sclerosis patients treated with disease-modifying therapies - the Polish experience.
Neurol Neurochir Pol;
55(2): 212-222, 2021.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33856686
2.
Evaluation of efficacy, safety and tolerability of fingolimod in patients with the relapsing form of multiple sclerosis - 12-month observation. A preliminary report.
Neurol Neurochir Pol;
47(2): 145-51, 2013.
Artigo
em Inglês
| MEDLINE
| ID: mdl-23650003
3.
Symptoms after COVID-19 Infection in Individuals with Multiple Sclerosis in Poland.
J Clin Med;
10(22)2021 Nov 10.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34830507
4.
Association of vitamin D status and clinical and radiological outcomes in a treated MS population in Poland.
Brain Behav;
7(2): e00609, 2017 02.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28239520